EUVIMEDEUVIMED entdecken
Crossref

1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility

ERIN COBRY, EMILY FIVEKILLER, LISA J. MELTZER, SARAH JASER, BENNETT STEWART, RAJ P. WADWA

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1567-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ERIN COBRY und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Sleep disturbances are common among adolescents with T1D and impact glycemic management and quality of life. Sleep health is rarely assessed in routine care. We evaluated sleep screening feasibility in adolescents and pediatric diabetes HCPs.

Methods

Adolescents with T1D (ages 11-17) and HCPs completed or reviewed a sleep screening survey including the PROMIS Sleep-Related Impairment and Sleep Disturbance 4-item scales, followed by questions focused on causes of sleep concerns and feasibility (table).

Results

Among adolescents (N=111, mean age 14.7±2.2yrs), mean completion time was 6.6±4.4 mins. 96% indicated feasibility during clinic check-in, which was also the preferred method (73%). 62% endorsed the screening as helpful in routine diabetes care and 64% valued discussing sleep with HCPs. Among HCPs (N=15), 87% reported patients endorsing sleep concerns. 60% indicated sufficient time to address sleep during visits. 73% estimated needing 1-9 min to discuss results. Preferred resources included patient handouts (100%), referral advice (87%), and diabetes management advice (87%).

Conclusion

Adolescents with T1D and HCPs found a brief sleep screening survey feasible, acceptable, and clinically relevant. Integrating sleep screening into diabetes care may facilitate identification of sleep concerns and support targeted interventions to improve adolescent well-being and diabetes management. Disclosure E. Cobry: None. E. Fivekiller: None. L.J. Meltzer: Consultant; Current; Egetis Therapeutics, Zepp Health. S. Jaser: Speaker's Bureau; Ended; Sanofi. B. Stewart: None. R.P. Wadwa: Advisory Panel; Current; Medtronic. Advisory Panel; Ended; Tandem Diabetes Care, Inc. Consultant; Ended; Tandem Diabetes Care, Inc. Research Support; Current; Tandem Diabetes Care, Inc. Consultant; Ended; Dexcom, Inc. Research Support; Ended; Dexcom, Inc. Funding Breakthrough T1D (5-ECR-2022-1179-A-N)

Zitieren

APA

COBRY, E., FIVEKILLER, E., MELTZER, L. J., JASER, S., STEWART, B., & WADWA, R. P. (2026). 1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1567-p

Vancouver

COBRY E, FIVEKILLER E, MELTZER LJ, JASER S, STEWART B, WADWA RP. 1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1567-p

BibTeX
@article{COBRY2026,
  author = {COBRY, ERIN and FIVEKILLER, EMILY and MELTZER, LISA J. and JASER, SARAH and STEWART, BENNETT and WADWA, RAJ P.},
  title = {1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1567-p}
}
Kostenlos starten →